By activating the MAPK and NF-κB pathways, which are downstream of neurotensin (NTS) signaling, IL-8 has been demonstrated to promote EMT and tumor invasion in hepatocellular carcinoma (HCC). The gene discussed is CXCL8; the disease is neoplasm.